The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially inflated the cost of insulin.

The FTC has released its second report digging into how the business practices of pharmacy benefit managers could be inflating drug costs in the U.S. RiverNorthPhotography via Getty Images Listen ...

Why the FTC is looking at pharmacy benefit managers and their role in drug pricing. The Federal Trade Commission says companies like CVS Caremark, Express Scripts and OptumRx are artificially ...

Pharmacy benefit manager reform fails to make the cut in federal funding package ... The Federal Trade Commission in September sued the largest PBMs — CVS Health’s Caremark Rx, ...

Among other findings, the FTC uncovered markups ranging from 188% for MMF as dispensed by a pharmacy benefit manager (PBM)-affiliated pharmacy, to 7,736% for tadalafil.

Just days after releasing an interim report blaming pharmacy benefit managers (PBM) for high prescription drug prices, the Federal Trade Commission (FTC) is reportedly prepared to take the ...

Cigna is following through on promises to more aggressively defend its pharmacy benefit manager. On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over ...

The Federal Trade Commission alleges that pharmacy benefits managers prioritized high rebates from drug makers for insulin over lower prices for consumers, leading to inflated out-of-pocket costs.

Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...

The Federal Trade Commission provided an example of the consequences of vertical integration, ... If a pharmacy benefit manager is working in a positive manner, ...

Pharmacy benefit manager reform fails to make the cut in federal funding package. ... The Federal Trade Commission in September sued the largest PBMs — CVS Health’s Caremark Rx, ...